Advances in predictive factors of neoadjuvant chemotherapy in breast cancer / 国际肿瘤学杂志

ABSTRACT

Predictive factors of neoadjuvant chemotherapy play an important role in selecting sensitive chemotherapy regimen and avoiding unsuitable regimen for breast cancer patients. At present, estrogen receptor (ER), progestin receptor (PR) and HER-2 status are the main predictive factors. Other factors such as Ki-67 also seem to be promising for optimizing neoadjuvant chemotherapy.